Hi Mots - the Company announcement on 26 Feb says that the expected receipt of funds allows the Company to start immediate planning for the PhaseIII clinical trial but it doesn't indicate when that trial may commence. I have submitted a request to Avexa to attempt to ascertain if they can give an indication of a commencement date. Will post the reply when I receive it.